Quris Earns Frost & Sullivan 2022 European Technology Innovation Leadership Award for AI-Powered Drug Safety Prediction
September 02, 2022
September 02, 2022
SAN ANTONIO, Texas, Sept. 2 (TNSres) -- Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services across multiple industries, issued the following news release:
* * *
Analysts found that the Quris Bio-AI Clinical Prediction Platform enhances drug development process agility, shortens discovery timelines, increases drug safety, and improves drug pipeline diversification opportunities
* * *
* * *
Analysts found that the Quris Bio-AI Clinical Prediction Platform enhances drug development process agility, shortens discovery timelines, increases drug safety, and improves drug pipeline diversification opportunities
* * *